Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women

Human Psychopharmacology

Volumn 26, Issue 6, 2011, Pages 412-421

  Metz, Verena ^a   Jagsch, Reinhold ^b   Ebner, Nina ^a   Würzl, Johanna ^a   Pribasnig, Anna ^a   Aschauer, Constantin ^a   Fischer, Gabriele ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

buprenorphine; methadone; neonatal abstinence syndrome; opioid dependence; pregnancy; treatment setting

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

ADULT; ARTICLE; AUSTRIA; BIRTH; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; NEWBORN CARE; NEWBORN PERIOD; OPIATE ADDICTION; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THIRD TRIMESTER PREGNANCY; UNIVERSITY; URINALYSIS; WITHDRAWAL SYNDROME;

ADULT; AUSTRIA; BIRTH WEIGHT; BUPRENORPHINE; DOUBLE-BLIND METHOD; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; METHADONE; MORPHINE; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 80052272375     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1224     Document Type: Article

References (42)

1. American Academy of Pediatrics Committee on Drugs. 1998. Neonatal withdrawal. Pediatrics 101: 1079-1087.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders-DSM-IV (4th edition). American Psychiatric Association: Washington, DC.
3. Berghella V, Lim PJ, Hill MK, Cerpes J, Chennat J, Kaltenbach K,. 2003. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 189: 312-317.
4. Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M, Murphy DJ,. 2010. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 105 (12): 2071-2084.
5. Dashe JS, Sheffield JS, Olscher DA, Todd SJ, Jackson GL, Wendel GD,. 2002. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 200: 1244-1249. (Pubitemid 35449191)
6. Dryden C, Young D, Hepburn M, Mactier H,. 2009. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 116 (5): 665-671.
7. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, Thau K, Fischer G,. 2007. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 87 (2-3): 131-138. (Pubitemid 46215932)
8. Fagerström KO, Schneider NG,. 1989. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med 12: 159-181.
9. Finnegan LP, Kron RE, Connaughton JF, Emich JP,. 1975. Assessment and treatment of abstinence in the infant of the drug dependent mother. International J Clin Pharm Biopharmacy 12: 19.
10. Fischer G,. Treatment of opioid dependence in pregnant women. 2000. Addiction 95 (8): 1141-1144. (Pubitemid 30644100)
11. Fischer G, Eder H, Jagsch R, Lennkh C, Habeler A, Aschauer HN, Kasper S,. 1998a. Maintenance therapy with synthetic opioids within a multidisciplinary program-a stabilizing necessity for pregnant opioid dependent women. Archives of Women's Mental Health 1: 109-116. (Pubitemid 128480564)
12. Fischer G, Etzersdorfer P, Eder H, Jagsch R, Langer M, Weninger M,. 1998b. Buprenorphine maintenance in pregnant opiate addicts. European Addiction Research 4 (S 1): 32-36. (Pubitemid 28478993)
13. Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger G, Pezawas L, Aschauer HN, Kasper S,. 1999. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 94 (9): 1337-1347. (Pubitemid 29433792)
14. Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, Langer M, Aschauer HN,. 2000. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction 95 (2): 239-244. (Pubitemid 30111244)
15. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H,. 2006. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 101 (2): 275-281. (Pubitemid 43351601)
16. Goeb JL, Coste J, Bigot T, Ferrand I,. 2000. Prospective study of favorable factors in follow-up of drug addicted patients-apropos of 257 patients of the Cassini Center in Paris. Encephale 26 (6): 11-20. (Pubitemid 32101437)
17. Goldkind SF, Sahin L, Gallauresi B,. 2010. Enrolling pregnant women in research-lessons from the H1N1 influenza pandemic. N Engl J Med 362 (24): 2241-2243.
18. Gsellhofer B, Küfner H, Vogt M, Weiler D,. 1999. European Addiction Severity Index (Europ-ASI)-Manual für Training und Durchführung. Schneider-Verlag: Hohengehren.
19. Gyarmathy VA, Giraudon I, Hedrich D, Montanari L, Guarita B, Wiessing L,. 2009. Drug use and pregnancy-challenges for public health. Euro Surveill 14 (9): 33-36.
20. Halbreich U, Smail N, Tu X, Halbreich J,. 2008. Participation in clinical trials may improve care of acute schizophrenia inpatients in a general hospital. CNS Spectr 13 (9): 757-761.
21. Heil SH, Higgins ST, Bernstein IM, Solomon LJ, Rogers RE, Thomas CS, Badger GJ, Lynch ME,. 2008. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 103 (6): 1009-1018. (Pubitemid 351703486)
22. Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L,. 2005. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 79 (1): 1-10. (Pubitemid 41557119)
23. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G,. 2010. Neonatal abstinence syndrome following methadone or buprenorphine exposure. NEJM 363 (24): 2320-2331.
24. Jones HE, Martin PR, Heil SH, Kaltenbach K, Selby P, Coyle MG, Stine SM, O'Grady KE, Arria AM, Fischer G,. 2008. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 35 (3): 245-259.
25. Kahila H, Saisto T, Kivitie-Kallio S, Haukkamaa M, Halmesmaki E,. 2007. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome. Acta Obstet Gynecol Scand 86: 185-190.
26. Kakko J, Heilig M, Sarman I,. 2008. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug and Alcohol Dependence 96: 69-78.
27. Kaltenbach K, Berghella V, Finnegan L,. 1998. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 25 (1): 139-151. (Pubitemid 28141705)
28. Kraigher D, Schindler S, Ortner R, Fischer G,. 2001. Pregnancy and substance dependency. Gesundheitswesen 63 (Suppl 2): S101-S105. (Pubitemid 33740653)
29. Lim S, Prasad M, Samuels P, Gardner D, Cordero L,. 2009. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. American Journal of Obstetrics and Gynecology 200 (1): 70.e1-70.e5.
30. Marquet P, Lavignasse P, Gaulier J-M, Lachatre G,. 2002. Case study of neonates born to mothers undergoing buprenorphine maintenance treatment. In Buprenorphine Therapy of Opiate Addiction, Kintz P, Marquet P, (eds). Human Press: Totowa, NJ; 125-135.
31. Morton J, Konrad SC,. 2009. Introducing a caring/relational framework for building relationships with addicted mothers. JOGNN 38 (2): 206-213.
32. Priebe S, Gruyters T, Heinze M, Hoffmann C, Jakel A,. 1999. Subjektive evaluationskriterien in der psychiatrischen versorgung-erhebungsmethoden für forschung und praxis. [Subjective evaluation criteria in psychiatric care-methods of assessment for research and general practice]. [German], Psychiatrische Praxis (Berlin) 22 (4): 140-144.
33. Rohrmeister K, Bernert G, Langer M, Fischer G, Weninger M, Pollak A,. 2001. Opiate addiction in gravidity-consequences for the newborn. Results of an interdisciplinary treatment concept. Z Geburtshilfe Neonatol 205 (6): 224-230. (Pubitemid 33151420)
34. Saiki T, Lee S, Hannam S, Greenough A,. 2010. Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. Eur J Pediatr 169 (1): 95-98.
35. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G,. 2003. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 98 (1): 103-110. (Pubitemid 36044342)
36. Schroder R, Sellman D, Frampton C, Deering D,. 2009. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment. Drug Alcohol Rev 28 (6): 663-668.
37. Simmat-Durand L, Lejeune C, Gourarier L,; Groupe d' Etudes Grossesse et Addictions (GEGA). 2009. Pregnancy under high-dose buprenorphine. Eur J Obstet Gynecol Reprod Biol 142 (2): 119-123.
38. Sullivan RD, Fischbach AL, Hornick FW,. 1972. Treatment of a pregnant opiate addict with oral methadone. Ariz Med 29 (2): 129-130.
39. Unger A, Jung E, Winklbaur B, Fischer G,. 2010a. Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis 29 (2): 217-230.
40. Unger AS, Martin PR, Kaltenbach K, Stine SM, Heil SH, Jones HE, Arria AM, Coyle MG, Selby P, Fischer G,. 2010b. Clinical characteristics of Central European and North American samples of pregnant women screened for opioid agonist treatment. Eur Addict Res 16 (2): 99-107.
41. Velez M, Jansson LM,. 2008. The opioid dependent mother and newborn dyad: non-pharmacologic care. J Addict Med 2 (3): 113-120.
42. Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G,. 2008. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 103 (9): 1429-1440.